Coloplast acquires Mpathy Medical and strengthens the company's position within Female Pelvic Health

HUMLEBAEK, Denmark, and Minneapolis, Minnesota October 29, 2010 — Coloplast
announced today that it has acquired Mpathy Medical, a fast growing company in
women's health, for a total cash consideration of USD 30m equal to DKK162m,
potentially increasing to a total of USD 35m equal to DKK 189m on a cash and
debt free basis. The acquisition expands the Coloplast female health portfolio
of innovative product technologies and surgical solutions for female stress
urinary incontinence and pelvic organ prolapse. 

Mpathy Medical gives Coloplast the lightest weight mesh technologies in the
world, less invasive pelvic restoration procedures, and an increased presence
in the U.S. female pelvic health specialties market. 

The Mpathy Medical acquisition is important in Coloplast's strategy to build a
strong market presence within the highly competitive USD 500m, US and EU female
pelvic health specialties market. The acquisition positions Coloplast for
technology leadership and accelerated growth. 

“I am very happy to announce this mutually beneficial acquisition,” said Dave
Amerson, Global Vice President, Coloplast Surgical Urology. “The acquisition of
Mpathy will strengthen our presence in the female pelvic health market and
raise the standard for innovation and patient outcomes in this market
worldwide. We will leverage the strengths and best practices of both companies,
which will give our customers access to an even stronger product portfolio and
innovative solutions for restoring female pelvic health.” 

Coloplast will combine the two companies' complementary products into the
Coloplast Surgical Urology division. 

“I'm very proud of Mpathy's accomplishments,” said James Browning, MD, founder
and chief technology officer of Mpathy Medical, “and by being a part of
Coloplast, we will improve our ability to provide technologically advanced
surgical solutions to physicians, and improve outcomes for women.” 

Coloplast will pursue an integration of personnel, operations and products
designed to ensure business continuity and exceptional customer service. 

About Coloplast 
Danish medical device company Coloplast develops products and services that
make life easier for people with very personal and private medical conditions.
Working closely with the people who use our products, we create solutions that
are sensitive to their special needs. We call this intimate healthcare. Our
business includes ostomy care, urology, continence care, and wound and skin
care. We operate globally and employ more than 7,000 people worldwide. In 2009,
Coloplast opened the new North American headquarters in Minneapolis, Minnesota.
The campus is LEED-certified (Leadership in Energy and Environmental Design)
and is home to one of the company's three global research-and-development
Innovation Centers. Others are located in Denmark and France. 
To learn more about Coloplast, visit www.coloplast.com.


About Mpathy Medical  
Mpathy Medical is a rapidly growing medical device company which has developed
and brought to market a range of surgical solutions used to restore pelvic
health to women. Mpathy Medical's core product lines - Restorelle®, Omnisure®
and Minitape® - are used by surgeons specializing in urogynecology, gynecology
and urology to treat female stress urinary incontinence (SUI) and pelvic floor
repair (PFR). The company is headquartered in Glasgow, Scotland, with U.S.
operations in Raynham, Massachusetts., and has received FDA 510(k) clearance to
market in the U.S. and CE marking in the EU for all its medical devices. 

To learn more about Mpathy Medical, visit www.mpathymedical.com.

PRESS CONTACT U.S.
Ayme Zemke
Group Director, Public Relations
+1 651.789.2235 
azemke@beehivepr.biz 


PRESS CONTACT OUTSIDE U.S.
Anders Monrad Rendtorff
SVP, People & Communications
+45 4911 1920
dkare@coloplast.com

Ulla Lundhus
Media Relations Manager
+45 4911 1929
dkul@coloplast.com

INVESTOR RELATIONS
Ian S. E. Christensen
Director of Investor Relations 
+45 4911 1301
dkisec@coloplast.com